bioRxivPharmacology & Toxicology
Mucin-mimetic action of capsaicin improves high fat diet-induced gut barrier dysfunction in mice colon
V. Kumar, V. Kumar, N. Mahajan, J. Kaur, K. Devi, R. N. Dharavath, R. P. Singh, K. K. Kondepudi, M. Bishnoi
Abstract
The gut barrier - including tight junction proteins and mucus layers, is the first line of defense against physical, chemical, or pathogenic incursions. This barrier is compromised in various health disorders. Capsaicin, a dietary agonist of Transient receptor potential vanilloid 1 (TRPV1) channel, is reported to alleviate the complications of obesity. While its mode of action is well established to enhance energy expenditure, metabolism and prevent dysbiosis, the more local effects on the host gut - particularly the gut barrier and mucus system remain elusive. We employed a diet-induced obesity model to investigate the effect of capsaicin on the gut barrier and mucus production and to understand the involvement of mucus, bacteria, and TRPV1 in these phenomena. Mucin feeding reflected most of the effects produced by capsaicin, indicating that mucus modulation by capsaicin plays a crucial role in its anti-obesity effects. Capsaicin, bacteria and the host mucus system seem to act in a cyclic cascade involving TRPV1, which can be activated by capsaicin and various bacteria. These findings provide new insight into the role of TRPV1 in maintaining a healthy gut environment. HIGHLIGHTSO_LIExogenous mucin feeding produced anti-obesity effects similar to capsaicin in mice. C_LIO_LIMucin and capsaicin improved TJP expression, intestinal permeability and gut microbial diversity. C_LIO_LICapsaicin modulated bacterial diversity in vitro, independently of the host. C_LIO_LIProbiotic bacteria and butyrate activated TRPV1 in transfected HEK cells. C_LIO_LIAnti-obesity action of capsaicin is not exclusive to TRPV1 agonism. C_LIO_LICapsaicins action as colonic mucus secretagogue - plays a crucial part in its anti-obesity benefits. C_LI
- organism: mouse
- assay: bulk RNA-seq
- research focus: host-pathogen & immune response
- approach: experimental assay
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Role of TRPV1 in colonic mucin production and gut microbiota profile
V. Kumar, N. Mahajan, … M. Bishnoi·bioRxiv·Apr 17, 2020
- Colon Innervating TRPA1 Positive Nociceptors Influence Mucosal Health In Mice
M. Bishnoi, V. Kumar, … K. Chopra·bioRxiv·Oct 17, 2021
- Sensitisation of colonic nociceptors by TNFα is dependent on TNFR1 expression and p38 MAPK activity
Katie H. Barker, James P. Higham, … David Colin Bulmer·The Journal of PhysiologyPeer-reviewed·Jul 1, 2022
- Attenuation of colitis-induced visceral hypersensitivity and pain by silencing TRPV1-expressing fibers in rat colon
Yoav Mazor, Nurit Engelmayer, … Alexander M. Binshtok·bioRxiv·Jun 27, 2023
- OBESITY-INDUCED ENDOTHELIAL FENESTRATION AND CAPILLARY LEAKAGE CONTRIBUTE TO INCREASED PAIN SENSATION
Yuta Koui, Jonathan Richard Shin, … Yoh‐suke Mukouyama·bioRxiv·Mar 16, 2026
- Calpain cleaves the carboxyl terminus of TRPV1 and modulates receptor tachyphylaxis
Jinyan Jiang, Xiaochen Wang, … Ying Zhang·bioRxiv·Apr 28, 2025